Atg4a activators belong to a specific class of molecules that play a crucial role in the regulation of autophagy, a fundamental cellular process responsible for the degradation and recycling of damaged or unnecessary cellular components. Autophagy is a finely tuned process that ensures cellular homeostasis by eliminating misfolded proteins, damaged organelles, and intracellular pathogens. Atg4a, short for Autophagy-related 4A, is an essential protein in this pathway, and its activators are compounds or molecules that modulate its activity to influence autophagic processes.
Atg4a activators primarily interact with the Atg4a protein to regulate its enzymatic activity. Atg4a is a cysteine protease that plays a pivotal role in the initial steps of autophagy. It is responsible for the cleavage of Atg8/LC3, a protein that is essential for autophagosome formation and cargo recruitment. By binding to Atg4a and modulating its activity, these activators can influence the efficiency of autophagy. They can either enhance or inhibit the cleavage of Atg8/LC3, thereby fine-tuning the autophagic process. This delicate control over autophagy can have significant implications for cellular homeostasis, as it allows cells to adapt to various stress conditions, including nutrient deprivation, pathogen invasion, and cellular damage. Understanding the mechanisms and potential applications of Atg4a activators is an area of ongoing research in cell biology, with implications for various fields.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin indirectly activates ATG4A by inhibiting mTOR, thus promoting ATG4A-mediated autophagy. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an Akt inhibitor that activates autophagy by inhibiting the Akt/mTOR pathway, leading to increased ATG4A activity. | ||||||
D-(+)-Trehalose Anhydrous | 99-20-7 | sc-294151 sc-294151A sc-294151B | 1 g 25 g 100 g | $30.00 $167.00 $260.00 | 2 | |
While primarily a natural disaccharide, trehalose activates ATG4A indirectly by enhancing autophagosome formation and cargo degradation. | ||||||
Spermidine | 124-20-9 | sc-215900 sc-215900B sc-215900A | 1 g 25 g 5 g | $57.00 $607.00 $176.00 | ||
Spermidine induces autophagy by inhibiting acetyltransferases, resulting in increased ATG4A activation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
VPA activates autophagy by modulating the mTOR signaling pathway, leading to increased ATG4A activity | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol, a polyphenolic compound, activates autophagy through various pathways, including AMPK, thereby promoting ATG4A-mediated autophagy. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin activates autophagy by stimulating AMPK, resulting in increased ATG4A activity. | ||||||
rac 2-Isopropyl Pentanoic Acid (Sodium Valproate Impurity C) | 62391-99-5 | sc-212703 | 50 mg | $240.00 | ||
sodium valproate modulates autophagy through mTOR inhibition, leading to increased ATG4A activation. | ||||||
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
hydroxychloroquine inhibits lysosomal function, promoting autophagy and increasing ATG4A activity. | ||||||